To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene DCUN1D5TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
419 supporting clones for gene DCUN1D5 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BX504758   .a 1 to 579 1 to 579   tiling clone,   579/579
(100 %)
2 diff
(99.7 %id)
DB161856 thymus .a 385 to 971 2 to 588   tiling clone, to resequence, capped   587/587
(100 %)
3 diff
(99.5 %id)
DB346914 thymus .a 1638 to 2183 546 to 1   tiling clone, to resequence,   546/546
(100 %)
0 diff
(100 %id)
BE274028 Kidney, renal cell adenocarcinoma .b 1 to 681 39 to 720   tiling clone,   684/774
(88 %)
17 diff
(97.9 %id)
AK298227   .b 13 to 1322 1 to 1310 exact tiling clone,   1310/1310
(100 %)
0 diff
(100 %id)
DC361215   .b 13 to 598 1 to 586       586/586
(100 %)
0 diff
(100 %id)
BE273943 Kidney, renal cell adenocarcinoma .b 15 to 669 1 to 653       653/689
(94 %)
16 diff
(97.7 %id)
BP222842   .b 16 to 600 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
DT215202 brain .b 25 to 600 1 to 576       576/577
(99 %)
4 diff
(99.4 %id)
CN481423 eye .b 46 to 581 1 to 536       536/536
(100 %)
0 diff
(100 %id)
BG326588 Kidney, renal cell adenocarcinoma .b 53 to 854 1 to 793       793/911
(87 %)
19 diff
(98.0 %id)
BP308110 brain .b 66 to 646 1 to 581       581/581
(100 %)
0 diff
(100 %id)
NM_032299.3   .c 1 to 12731 2 to 12732 exact RefSeq,   12732/12732
(100 %)
0 diff
(100 %id)
DB039638 testis .c 1 to 573 2 to 574   tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
BG031037 breast, mammary adenocarcinoma, cell line .c 21 to 689 1 to 666       666/907
(73 %)
10 diff
(98.9 %id)
BM473646 melanotic melanoma, skin .c 21 to 1001 13 to 995       983/1103
(89 %)
25 diff
(97.8 %id)
BP245935 Kidney .c 22 to 645 1 to 624       624/624
(100 %)
5 diff
(99.2 %id)
BP246833 Kidney .c 22 to 610 1 to 587       587/587
(100 %)
10 diff
(98.3 %id)
CX753604 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 22 to 607 1 to 587     Submitted on the opposite strand 587/797
(73 %)
14 diff
(98.3 %id)
BP320510 placenta .c 22 to 591 1 to 570       570/593
(96 %)
2 diff
(99.7 %id)
BP247100 Kidney .c 25 to 607 1 to 582       582/582
(100 %)
22 diff
(96.3 %id)
BP299129   .c 25 to 591 1 to 568       568/581
(97 %)
3 diff
(99.5 %id)
CD390046 embryonic trophoblasts, made from WA01 stemcells .c 26 to 893 25 to 893       869/893
(97 %)
7 diff
(99.3 %id)
DA609848   .c 26 to 580 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BI464099 testis .c 31 to 897 1 to 874       874/1111
(78 %)
30 diff
(97.3 %id)
TI_57243893   .c 31 to 764 22 to 752       731/752
(97 %)
8 diff
(99.0 %id)
CN261959 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 32 to 681 1 to 652       652/652
(100 %)
6 diff
(99.1 %id)
AA099966 colon, tumor .c 35 to 431 1 to 397       397/408
(97 %)
10 diff
(97.6 %id)
BG715278 brain, hypothalamus .c 36 to 795 1 to 759       759/818
(92 %)
22 diff
(97.4 %id)
BG715673 brain, hypothalamus .c 36 to 742 1 to 707       707/707
(100 %)
13 diff
(98.2 %id)
BI602001 brain, hypothalamus .c 36 to 897 1 to 869       809/953
(84 %)
22 diff
(97.7 %id)
CB997957 placenta, pre-eclamptic placenta .c 36 to 780 28 to 783       756/788
(95 %)
21 diff
(97.4 %id)
DT220977 brain .c 38 to 692 1 to 655       655/655
(100 %)
0 diff
(100 %id)
BP246169 Kidney .c 38 to 615 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
BP246733 Kidney .c 38 to 637 1 to 602       602/602
(100 %)
2 diff
(99.7 %id)
BI917774 brain .c 38 to 764 1 to 724       724/724
(100 %)
3 diff
(99.6 %id)
BP354818   .c 38 to 617 1 to 582       582/582
(100 %)
10 diff
(98.3 %id)
BP260485 small intestine .c 40 to 604 1 to 565       565/570
(99 %)
3 diff
(99.5 %id)
DB503930 hypothalamus .c 41 to 378 1 to 338       338/338
(100 %)
2 diff
(99.5 %id)
DB505963 hypothalamus .c 41 to 541 1 to 501       501/501
(100 %)
2 diff
(99.7 %id)
TI_45209994   .c 41 to 897 82 to 945       864/1029
(83 %)
24 diff
(97.7 %id)
DA511952 brain .c 42 to 601 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
BF973110 leiomyosarcoma cell line, uterus .c 42 to 555 1 to 517       517/896
(57 %)
11 diff
(98.8 %id)
BU507540 leiomyosarcoma, uterus .c 42 to 881 44 to 891       848/894
(94 %)
17 diff
(98.1 %id)
CB989317 Human Placenta, placenta .c 42 to 780 29 to 773       745/849
(87 %)
16 diff
(98.2 %id)
BI091739 cervix .c 43 to 793 1 to 753       753/768
(98 %)
15 diff
(98.1 %id)
BI090178 cervix .c 44 to 793 1 to 760       760/875
(86 %)
21 diff
(97.6 %id)
BG697486 skin .c 46 to 805 1 to 759       759/759
(100 %)
5 diff
(99.4 %id)
CR596583 Placenta Cot 25-normalized .c 48 to 1310 1 to 1263 exact     1263/1263
(100 %)
0 diff
(100 %id)
CR625928 Placenta Cot 25-normalized .c 48 to 1281 1 to 1234 exact     1234/1234
(100 %)
0 diff
(100 %id)
AL552050 placenta, Placenta Cot 25-normalized .c 48 to 714 1 to 666   fully sequenced,   666/666
(100 %)
3 diff
(99.6 %id)
AL551112 placenta, Placenta Cot 25-normalized .c 48 to 714 1 to 668   fully sequenced,   668/668
(100 %)
2 diff
(99.8 %id)
CN261960 embryonic stem cells, cell lines H1, H7, andH9 .c 49 to 750 17 to 719       703/719
(97 %)
7 diff
(99.1 %id)
AA312411   .c 50 to 498 1 to 450       450/450
(100 %)
4 diff
(99.2 %id)
BP245906 Kidney .c 50 to 653 1 to 604       604/604
(100 %)
2 diff
(99.7 %id)
DB442764 testis .c 51 to 298 1 to 249       249/258
(96 %)
12 diff
(95.4 %id)
DB446282 testis .c 51 to 495 1 to 444       444/444
(100 %)
5 diff
(98.9 %id)
DA614850   .c 51 to 624 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
BP308600 brain .c 51 to 631 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
DA799212 brain .c 51 to 579 2 to 531   capped   530/530
(100 %)
1 diff
(99.9 %id)
AV721055 hypothalamus .c 52 to 676 1 to 616       616/734
(83 %)
19 diff
(97.5 %id)
TI_57188322   .c 52 to 859 50 to 861       812/812
(100 %)
12 diff
(98.6 %id)
BP320322 placenta .c 52 to 646 1 to 598       598/598
(100 %)
11 diff
(98.2 %id)
BP246552 Kidney .c 53 to 634 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BI859256 breast, mammary adenocarcinoma, cell line .c 53 to 859 1 to 811       811/811
(100 %)
12 diff
(98.6 %id)
CX760949 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 53 to 765 1 to 705       705/878
(80 %)
16 diff
(98.2 %id)
DA881651   .c 53 to 622 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
BP354727   .c 53 to 634 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP356056   .c 53 to 631 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BQ952656 carcinoma, cell line, Prostate .c 54 to 589 1 to 536       536/1028
(52 %)
13 diff
(98.8 %id)
BU553178 ovary, teratocarcinoma, cell line .c 54 to 840 1 to 791       791/907
(87 %)
8 diff
(99.2 %id)
BP352569   .c 55 to 671 1 to 617       617/617
(100 %)
0 diff
(100 %id)
TI_154179847   .c 55 to 685 76 to 707       632/861
(73 %)
18 diff
(98.0 %id)
DA759228   .c 56 to 597 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
CR599845 neuroblastoma .c 57 to 1308 1 to 1252 exact     1252/1252
(100 %)
0 diff
(100 %id)
CR602483 fetal liver .c 57 to 1297 1 to 1241 exact     1241/1241
(100 %)
0 diff
(100 %id)
CR625325 Neuroblastoma Cot 25-normalized .c 57 to 1210 1 to 1154 exact     1154/1154
(100 %)
0 diff
(100 %id)
DB448300 testis .c 57 to 487 1 to 431       431/431
(100 %)
0 diff
(100 %id)
DA322299 hippocampus .c 60 to 591 2 to 534   capped   533/542
(98 %)
2 diff
(99.7 %id)
CN261955 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 60 to 490 1 to 432       432/432
(100 %)
3 diff
(99.4 %id)
BU845614 ovary, teratocarcinoma, cell line .c 60 to 950 1 to 897       897/931
(96 %)
11 diff
(98.9 %id)
CB129919 Liver .c 60 to 530 1 to 471       471/471
(100 %)
0 diff
(100 %id)
CN261957 embryonic stem cells, DMSO-treated H9 cellline .c 61 to 194 1 to 134       134/134
(100 %)
4 diff
(97.1 %id)
AL525722 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 61 to 714 1 to 659   fully sequenced,   663/663
(100 %)
9 diff
(98.7 %id)
CF147248 CNCAP(3)T-225 cell line, Prostate .c 61 to 591 1 to 543       555/553
(100 %)
59 diff
(89.4 %id)
BP308601 brain .c 61 to 595 1 to 544       554/583
(95 %)
70 diff
(88.0 %id)
DN994708 brain, whole brain .c 61 to 784 2 to 734       742/734
(101 %)
56 diff
(92.4 %id)
BP355280   .c 62 to 643 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BF304919 muscle, rhabdomyosarcoma .c 63 to 858 1 to 795       796/862
(92 %)
35 diff
(96.0 %id)
BF315024 brain, neuroblastoma .c 63 to 801 1 to 737       737/811
(90 %)
32 diff
(96.1 %id)
BI195930 brain, neuroblastoma .c 63 to 758 1 to 698       698/701
(99 %)
10 diff
(98.6 %id)
CX786354 human embryonic stem cells .c 63 to 859 1 to 797       797/797
(100 %)
0 diff
(100 %id)
BP244914 Kidney .c 64 to 644 1 to 581       581/581
(100 %)
6 diff
(99.0 %id)
BE263003 brain, neuroblastoma .c 64 to 397 21 to 353       333/353
(94 %)
6 diff
(98.4 %id)
TI_44166017   .c 64 to 808 109 to 856       748/856
(87 %)
17 diff
(98.1 %id)
BI546080 brain, hippocampus .c 65 to 808 1 to 747       745/747
(99 %)
15 diff
(98.0 %id)
BQ215851 large cell carcinoma, lung .c 65 to 793 27 to 758       732/857
(85 %)
15 diff
(98.3 %id)
BF792443 adrenal cortex carcinoma, cell line, adrenal gland .c 68 to 847 1 to 775       778/964
(80 %)
18 diff
(98.2 %id)
BM908824 astrocytoma grade IV, cell line, brain .c 68 to 895 8 to 836       828/1120
(73 %)
19 diff
(98.4 %id)
BM562658 astrocytoma grade IV, cell line, brain .c 68 to 895 1 to 829       829/1070
(77 %)
11 diff
(99.0 %id)
BM563001 astrocytoma grade IV, cell line, brain .c 68 to 1001 1 to 935       935/1036
(90 %)
10 diff
(99.1 %id)
BG025833 lymph, lymphoma, cell line .c 69 to 527 1 to 460       460/558
(82 %)
4 diff
(99.3 %id)
CX758030 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 70 to 591 39 to 560     Submitted on the opposite strand 522/780
(66 %)
17 diff
(97.9 %id)
BE276965 melanotic melanoma, skin .c 71 to 747 1 to 676       676/745
(90 %)
13 diff
(98.3 %id)
BE389217 endometrium, adenocarcinoma cell line, uterus .c 71 to 716 1 to 643       643/644
(99 %)
9 diff
(98.7 %id)
BE391366 endometrium, adenocarcinoma cell line, uterus .c 71 to 542 1 to 472       472/666
(70 %)
3 diff
(99.6 %id)
BE388113 endometrium, adenocarcinoma cell line, uterus .c 71 to 746 1 to 670       668/714
(93 %)
21 diff
(97.1 %id)
BE390060 endometrium, adenocarcinoma cell line, uterus .c 71 to 685 1 to 617       617/679
(90 %)
3 diff
(99.6 %id)
BE384303 melanotic melanoma, skin .c 71 to 643 1 to 566       567/604
(93 %)
10 diff
(98.4 %id)
BF125789 melanotic melanoma, skin .c 71 to 591 1 to 518       518/816
(63 %)
7 diff
(99.2 %id)
BM042352 melanotic melanoma, cell line, skin .c 71 to 483 1 to 410   fully sequenced,   410/410
(100 %)
8 diff
(98.1 %id)
BQ677202 melanotic melanoma, cell line, skin .c 71 to 897 17 to 850       834/920
(90 %)
21 diff
(97.8 %id)
CT002266 T-Lymphocytes .c 71 to 910 8 to 853       844/854
(98 %)
12 diff
(98.6 %id)
CR981295 T-Lymphocytes .c 71 to 754 1 to 684       684/684
(100 %)
1 diff
(99.9 %id)
CN261958 embryonic stem cells, DMSO-treated H9 cellline .c 72 to 395 1 to 324       324/324
(100 %)
1 diff
(99.7 %id)
BG283627 adenocarcinoma, cell line, Prostate .c 72 to 690 1 to 619       619/620
(99 %)
0 diff
(100 %id)
BQ215087 large cell carcinoma, lung .c 72 to 795 23 to 747       725/888
(81 %)
10 diff
(98.9 %id)
BG119203 adenocarcinoma, cell line, Liver .c 73 to 701 1 to 625       625/625
(100 %)
12 diff
(98.1 %id)
BQ050460 leiomyosarcoma, uterus .c 73 to 685 1 to 624       624/1227
(50 %)
25 diff
(98.0 %id)
BU173607 melanotic melanoma, cell line, skin .c 73 to 684 1 to 616       616/994
(61 %)
16 diff
(98.4 %id)
BQ682473 melanotic melanoma, cell line, skin .c 73 to 985 1 to 913       913/914
(99 %)
9 diff
(99.1 %id)
BU168370 melanotic melanoma, cell line, skin .c 73 to 959 1 to 898       898/907
(99 %)
22 diff
(97.6 %id)
BU180449 melanotic melanoma, cell line, skin .c 73 to 793 1 to 730       728/927
(78 %)
30 diff
(96.8 %id)
BQ680253 melanotic melanoma, cell line, skin .c 73 to 995 1 to 945       943/963
(97 %)
40 diff
(95.9 %id)
BU196731 melanotic melanoma, cell line, skin .c 73 to 793 1 to 722       722/962
(75 %)
15 diff
(98.5 %id)
AW246258 lung, small cell carcinoma .c 74 to 530 9 to 465       457/465
(98 %)
6 diff
(98.8 %id)
BG281085 melanotic melanoma, skin .c 74 to 942 1 to 862       862/862
(100 %)
28 diff
(96.8 %id)
BG282289 melanotic melanoma, skin .c 74 to 591 1 to 521       521/978
(53 %)
9 diff
(99.1 %id)
BG478184 melanotic melanoma, skin .c 74 to 891 1 to 817       817/817
(100 %)
12 diff
(98.6 %id)
BI115761 lung, small cell carcinoma .c 74 to 793 1 to 727       726/848
(85 %)
31 diff
(96.4 %id)
BQ929706 leiomyosarcoma, uterus .c 74 to 896 1 to 833       833/935
(89 %)
18 diff
(98.1 %id)
BU902674 leiomyosarcoma, uterus .c 74 to 990 1 to 928       926/936
(98 %)
13 diff
(98.7 %id)
BC004169 Lung, small cell carcinoma .c 75 to 1322 1 to 1248 exact available from MGC, AAA   1248/1248
(100 %)
0 diff
(100 %id)
CR597372 Neuroblastoma Cot 10-normalized .c 76 to 1287 1 to 1212 exact     1212/1212
(100 %)
0 diff
(100 %id)
AL519852 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 76 to 714 1 to 639   fully sequenced,   639/639
(100 %)
1 diff
(99.9 %id)
CN261953 embryonic stem cells, DMSO-treated H9 cellline .c 77 to 578 1 to 502       502/502
(100 %)
2 diff
(99.7 %id)
CN261956 embryonic stem cells, DMSO-treated H9 cellline .c 77 to 786 1 to 710       710/710
(100 %)
2 diff
(99.8 %id)
BU174950 epidermoid carcinoma, cell line, salivary gland .c 77 to 660 1 to 587       587/1067
(55 %)
13 diff
(98.8 %id)
BF307353 muscle, rhabdomyosarcoma .c 81 to 795 1 to 718       715/758
(94 %)
31 diff
(96.0 %id)
BU157666 ductal carcinoma, cell line, Pancreas .c 83 to 896 1 to 833       833/920
(90 %)
27 diff
(97.1 %id)
BE266808 lung, small cell carcinoma .c 87 to 665 1 to 581       581/581
(100 %)
14 diff
(97.6 %id)
AK056993 skeletal muscle .c 89 to 1322 1 to 1234 exact available from FLJ,   1234/1234
(100 %)
0 diff
(100 %id)
BE544851 cervical carcinoma cell line, cervix .c 89 to 849 1 to 758       758/762
(99 %)
19 diff
(97.6 %id)
BF686529 leiomyosarcoma cell line, uterus .c 89 to 895 1 to 800       803/954
(84 %)
30 diff
(96.9 %id)
DA893948 skeletal muscle .c 90 to 623 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
BP236453 coronary artery .c 91 to 676 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
BE265722 lung, small cell carcinoma .c 92 to 618 1 to 533       531/715
(74 %)
8 diff
(98.9 %id)
BF036778 adenocarcinoma, ovary .c 92 to 631 1 to 540       540/540
(100 %)
1 diff
(99.9 %id)
AW672758 lung, small cell carcinoma .c 93 to 522 1 to 429       429/429
(100 %)
6 diff
(98.7 %id)
BE384867 melanotic melanoma, skin .c 93 to 795 1 to 701       701/709
(98 %)
8 diff
(98.9 %id)
CD048158 embryonic stem cells, WA01, passage 38 .c 94 to 980 17 to 906       890/910
(97 %)
15 diff
(98.4 %id)
BE385658 melanotic melanoma, skin .c 95 to 795 1 to 696       696/707
(98 %)
23 diff
(96.8 %id)
BE888955 leiomyosarcoma, uterus .c 95 to 872 1 to 770       772/954
(80 %)
31 diff
(96.8 %id)
CN261951 embryonic stem cells, DMSO-treated H9 cellline .c 96 to 518 1 to 423       423/423
(100 %)
1 diff
(99.8 %id)
CR997091 T-Lymphocytes .c 96 to 808 1 to 713       713/714
(99 %)
1 diff
(99.9 %id)
BE279716 choriocarcinoma, placenta .c 97 to 707 1 to 616       616/617
(99 %)
7 diff
(98.9 %id)
BU508525 leiomyosarcoma, uterus .c 97 to 979 1 to 890       890/890
(100 %)
12 diff
(98.7 %id)
CN261952 embryonic stem cells, cell lines H1, H7, andH9 .c 98 to 428 1 to 331       331/332
(99 %)
2 diff
(99.4 %id)
BP261983 small intestine .c 99 to 680 1 to 582       582/582
(100 %)
0 diff
(100 %id)
CX867441 embryonic stem .c 99 to 857 1 to 759       759/759
(100 %)
0 diff
(100 %id)
CX867442 embryonic stem .c 99 to 892 1 to 794       794/794
(100 %)
0 diff
(100 %id)
BP245151 Kidney .c 108 to 694 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
DA894962 skeletal muscle .c 109 to 662 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
BP244844 Kidney .c 110 to 696 1 to 587       587/587
(100 %)
0 diff
(100 %id)
BP313775 mammary gland .c 110 to 690 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA396732 thalamus .c 111 to 708 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
BU183629 melanotic melanoma, skin .c 111 to 972 12 to 885       872/886
(98 %)
31 diff
(96.6 %id)
CR590369 Neuroblastoma Cot 50-normalized .c 113 to 1331 1 to 1219 exact tiling clone,   1219/1219
(100 %)
0 diff
(100 %id)
BX334224 Neuroblastoma Cot 50-normalized .c 113 to 928 1 to 816   fully sequenced,   816/816
(100 %)
1 diff
(99.9 %id)
BE397321 Burkitt lymphoma, lymph .c 115 to 669 1 to 555       555/555
(100 %)
0 diff
(100 %id)
BI252077 hepatocellular carcinoma, cell line, Liver .c 115 to 672 1 to 562   fully sequenced,   562/562
(100 %)
9 diff
(98.4 %id)
BE787679 large cell carcinoma, lung .c 117 to 793 1 to 695       621/762
(81 %)
39 diff
(94.9 %id)
BM809205 amelanotic melanoma, cell line, skin .c 119 to 1165 1 to 1051 V191G F227I V228C E229*     1051/1051
(100 %)
18 diff
(98.3 %id)
BQ069272 brain, neuroblastoma, cell line .c 119 to 1001 1 to 885       885/990
(89 %)
5 diff
(99.5 %id)
BQ647053 hepatocellular carcinoma, cell line, Liver .c 119 to 1028 1 to 912       912/916
(99 %)
8 diff
(99.2 %id)
BQ648864 hepatocellular carcinoma, cell line, Liver .c 119 to 1028 1 to 915       913/916
(99 %)
11 diff
(98.8 %id)
BQ646095 hepatocellular carcinoma, cell line, Liver .c 119 to 725 1 to 609       609/1054
(57 %)
6 diff
(99.5 %id)
BP332623 renal proximal tubule .c 120 to 689 1 to 571       571/583
(97 %)
5 diff
(99.2 %id)
BP354827   .c 120 to 689 1 to 570       570/584
(97 %)
5 diff
(99.2 %id)
CN261962 embryonic stem cells, cell lines H1, H7, andH9 .c 122 to 423 1 to 301       301/301
(100 %)
4 diff
(98.7 %id)
BG395930 eye, retinoblastoma .c 122 to 793 1 to 676       676/967
(69 %)
15 diff
(98.5 %id)
ES310949 scalp interfollicular dermis, skin .c 123 to 618 1 to 499       499/501
(99 %)
7 diff
(98.7 %id)
BE263201 brain, neuroblastoma .c 126 to 654 1 to 536       536/536
(100 %)
16 diff
(97.1 %id)
ES312150 frontal balding hair, skin .c 129 to 277 1 to 145       145/145
(100 %)
2 diff
(98.7 %id)
BG822709 adenocarcinoma cell line, colon .c 141 to 932 1 to 790       791/790
(100 %)
7 diff
(99.2 %id)
CN261963 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 142 to 877 1 to 736       736/736
(100 %)
0 diff
(100 %id)
BE730880 choriocarcinoma, placenta .c 143 to 995 1 to 839       839/944
(88 %)
28 diff
(97.1 %id)
BE867694 adenocarcinoma, colon .c 143 to 812 1 to 669       669/672
(99 %)
23 diff
(96.6 %id)
BE730832 choriocarcinoma, placenta .c 145 to 958 1 to 797       799/935
(85 %)
34 diff
(96.4 %id)
CA455200   .c 160 to 988 1 to 832       832/844
(98 %)
6 diff
(99.3 %id)
BE311766 Kidney, renal cell adenocarcinoma .c 161 to 793 1 to 637       637/709
(89 %)
14 diff
(98.1 %id)
CN261954 embryonic stem cells, cell lines H1, H7, andH9 .c 165 to 839 19 to 694       676/694
(97 %)
6 diff
(99.2 %id)
BP353730   .c 169 to 748 1 to 580       580/582
(99 %)
1 diff
(99.9 %id)
BM846688 myeloma .c 183 to 694 1 to 512       512/512
(100 %)
0 diff
(100 %id)
BE730577 melanotic melanoma, skin .c 240 to 881 222 to 859       637/859
(74 %)
23 diff
(97.4 %id)
BE277609 melanotic melanoma, skin .c 259 to 1052 17 to 807   available from MGC,   791/1130
(70 %)
17 diff
(98.5 %id)
BC021074 Skin, melanotic melanoma. .c 266 to 1322 1 to 1057 exact available from MGC, AAA   1057/1057
(100 %)
0 diff
(100 %id)
AL515497 brain, neuroblastoma, neuroblastoma cells .c 298 to 1238 1008 to 71 P2E V3E K5R R7S K8P ... AAA   938/1026
(91 %)
18 diff
(98.3 %id)
BI226105 Burkitt lymphoma, lymph .c 316 to 1019 1 to 703       703/703
(100 %)
1 diff
(99.9 %id)
AY364246   .c 343 to 1037 1 to 696       696/700
(99 %)
4 diff
(99.5 %id)
CV027173 mixed .c 343 to 1000 1 to 656       656/663
(98 %)
3 diff
(99.6 %id)
TI_1948084963   .c 343 to 995 121 to 781     Submitted on the opposite strand 661/1344
(49 %)
29 diff
(97.9 %id)
TI_1948085056   .c 345 to 714 125 to 494   fully sequenced,   370/494
(74 %)
6 diff
(98.8 %id)
TI_1948085247   .c 345 to 714 129 to 498   fully sequenced,   370/498
(74 %)
6 diff
(98.8 %id)
CR601995 Neuroblastoma Cot 25-normalized .c 395 to 1327 1 to 933       933/933
(100 %)
0 diff
(100 %id)
AL527399 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 395 to 1319 1 to 926   fully sequenced,   926/926
(100 %)
4 diff
(99.6 %id)
BM741543 stomach .c 406 to 1018 1 to 613       613/613
(100 %)
0 diff
(100 %id)
W27625 eye, retina .c 406 to 898 31 to 526       496/574
(86 %)
12 diff
(98.0 %id)
BE937913 testis_normal .c 432 to 719 9 to 301       299/301
(99 %)
7 diff
(97.7 %id)
TI_149287179   .c 441 to 1322 949 to 80   AAA   871/1142
(76 %)
32 diff
(97.2 %id)
BF349610 head_neck .c 449 to 862 14 to 428       415/433
(95 %)
9 diff
(98.0 %id)
BQ349566 head_neck .c 449 to 862 14 to 428       415/433
(95 %)
9 diff
(98.0 %id)
BM042955 melanotic melanoma, cell line, skin .c 453 to 1268 835 to 4   fully sequenced,   832/835
(99 %)
78 diff
(90.7 %id)
BU859384 ovary, teratocarcinoma, cell line .c 477 to 1329 1 to 855   AAA   855/855
(100 %)
5 diff
(99.5 %id)
BM833801 stomach .c 509 to 1100 1 to 592       592/592
(100 %)
1 diff
(99.9 %id)
CA336517 posterior rhombomeres 5-8 (4 pooled) .c 526 to 1140 1 to 615       615/615
(100 %)
1 diff
(99.9 %id)
BE925766 breast_normal .c 540 to 897 387 to 29       357/387
(92 %)
20 diff
(94.9 %id)
BP236047 coronary artery .c 560 to 1143 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA235523 brain .c 599 to 1180 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
BU182055 eye, retinoblastoma .c 623 to 1512 1 to 898   tiling clone,   898/898
(100 %)
19 diff
(97.9 %id)
BI252699 hepatocellular carcinoma, cell line, Liver .c 642 to 1258 645 to 29   fully sequenced,   617/645
(95 %)
0 diff
(100 %id)
BF000393 colon, colon tumor, RER+ .c 652 to 1323 674 to 2       673/674
(99 %)
3 diff
(99.6 %id)
AL519851 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 653 to 1284 637 to 4   fully sequenced,   614/617
(99 %)
13 diff
(97.9 %id)
AL562589 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 653 to 1210 567 to 1   fully sequenced,   567/567
(100 %)
18 diff
(96.9 %id)
AL527358 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 653 to 1265 637 to 27   fully sequenced,   611/637
(95 %)
4 diff
(99.4 %id)
AL575573 placenta, Placenta Cot 25-normalized .c 653 to 1310 657 to 1   fully sequenced,   657/657
(100 %)
5 diff
(99.3 %id)
AL574774 placenta, Placenta Cot 25-normalized .c 653 to 1281 627 to 1   fully sequenced,   627/627
(100 %)
4 diff
(99.4 %id)
TI_1948085057   .c 653 to 1046 525 to 132   fully sequenced,   394/525
(75 %)
0 diff
(100 %id)
TI_1948085248   .c 653 to 1055 527 to 125   fully sequenced,   403/527
(76 %)
0 diff
(100 %id)
AA055433 heart .c 655 to 1082 1 to 427       427/427
(100 %)
2 diff
(99.6 %id)
BQ649694 hepatocellular carcinoma, cell line, Liver .c 656 to 1339 1 to 684   AAA   684/684
(100 %)
0 diff
(100 %id)
BU634060 cell lines, Chondrosarcoma .c 656 to 1330 693 to 19   AAA   675/675
(100 %)
15 diff
(97.8 %id)
BX114897 heart .c 657 to 1328 1 to 670   AAA   670/670
(100 %)
3 diff
(99.6 %id)
AA362916 ovary .c 659 to 898 8 to 249       242/264
(91 %)
11 diff
(95.9 %id)
AI962602 pooled germ cell tumors .c 662 to 1329 678 to 11   AAA   668/669
(99 %)
0 diff
(100 %id)
BQ002604 Chondrosarcoma, Left Pelvis .c 663 to 1322 678 to 19   AAA   660/660
(100 %)
1 diff
(99.9 %id)
BM972541 lung .c 663 to 1322 678 to 19   AAA   660/662
(99 %)
3 diff
(99.6 %id)
AW084179 esophagus, squamous cell carcinoma .c 684 to 1340 660 to 1       660/662
(99 %)
14 diff
(97.9 %id)
BQ019329 Chondrosarcoma, Left Pubic Bone .c 684 to 1328 659 to 15   AAA   645/648
(99 %)
2 diff
(99.7 %id)
BM991961 Bone, Subchondral Bone .c 684 to 1330 665 to 19   AAA   647/647
(100 %)
0 diff
(100 %id)
BG189383   .c 687 to 928 1 to 242       242/242
(100 %)
1 diff
(99.6 %id)
AW263053 Kidney .c 694 to 1327 634 to 1       634/634
(100 %)
5 diff
(99.3 %id)
BE795039 lung, small cell carcinoma .c 709 to 1334 1 to 627       627/631
(99 %)
3 diff
(99.6 %id)
CA431067 cell lines, Chondrosarcoma .c 710 to 1344 653 to 19   AAA   635/641
(99 %)
0 diff
(100 %id)
AA877583 colon, colon tumor RER+ .c 718 to 1051 334 to 1       334/334
(100 %)
9 diff
(97.4 %id)
BE049408 adenocarcinoma, Pancreas .c 724 to 1336 617 to 6       612/617
(99 %)
2 diff
(99.7 %id)
BP224302 colon mucosa .c 732 to 1037 1 to 306       306/315
(97 %)
1 diff
(99.7 %id)
AW999828 breast_normal .c 755 to 910 20 to 176       157/176
(89 %)
15 diff
(91.5 %id)
BF984396 duodenal adenocarcinoma, cell line, small intestine .c 758 to 1324 1 to 566   AAA   566/566
(100 %)
1 diff
(99.9 %id)
AI671396 Kidney .c 763 to 1327 568 to 3       566/568
(99 %)
4 diff
(99.3 %id)
AI393247 B-cell, chronic lymphotic leukemia .c 766 to 1330 567 to 3       565/567
(99 %)
5 diff
(99.2 %id)
CR619246 T cells (Jurkat cell line) Cot10-normalized .c 768 to 1341 1 to 574       574/574
(100 %)
0 diff
(100 %id)
AL559387 T cells from T cell leukemia .c 768 to 1341 1 to 574   fully sequenced,   574/574
(100 %)
0 diff
(100 %id)
BE348265 Kidney .c 769 to 1327 559 to 1       559/559
(100 %)
1 diff
(99.9 %id)
DB330938 skeletal muscle .c 782 to 1322 541 to 1       541/541
(100 %)
0 diff
(100 %id)
BE220591 carcinoid, lung .c 784 to 1316 549 to 16       534/549
(97 %)
3 diff
(99.5 %id)
TI_1948085169   .c 785 to 1055 397 to 127       271/298
(90 %)
0 diff
(100 %id)
AW673090 cervix .c 790 to 988 1 to 199   fully sequenced,   199/199
(100 %)
0 diff
(100 %id)
AI215805 carcinoid, lung .c 791 to 1330 543 to 4       540/550
(98 %)
1 diff
(99.9 %id)
AI688503 colon .c 794 to 1336 546 to 4       543/574
(94 %)
5 diff
(99.2 %id)
CR606495 Placenta Cot 25-normalized .c 799 to 1327 1 to 529       529/529
(100 %)
0 diff
(100 %id)
BX357146 Placenta Cot 25-normalized .c 799 to 1327 1 to 529   fully sequenced,   529/529
(100 %)
1 diff
(99.9 %id)
BG777284 lung, mucoepidermoid carcinoma .c 805 to 1335 1 to 533       533/891
(59 %)
12 diff
(98.7 %id)
CD389999 embryonic trophoblasts, made from WA01 stemcells .c 806 to 1301 9 to 512       503/916
(54 %)
15 diff
(98.4 %id)
BP226332   .c 808 to 1328 1 to 521   AAA   521/521
(100 %)
0 diff
(100 %id)
AA666401   .c 809 to 1319 520 to 10       511/520
(98 %)
0 diff
(100 %id)
AI333898 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 823 to 1330 511 to 4       508/511
(99 %)
0 diff
(100 %id)
AW235139 pooled germ cell tumors .c 835 to 1330 499 to 1       499/499
(100 %)
3 diff
(99.4 %id)
AW952000   .c 840 to 1336 7 to 503       497/692
(71 %)
7 diff
(99.0 %id)
T30363 colon, endothelial .c 840 to 1123 8 to 292       285/292
(97 %)
8 diff
(97.3 %id)
DB527779 testis .c 843 to 1328 1 to 486     Submitted on the opposite strand 486/488
(99 %)
2 diff
(99.6 %id)
DB577267 hypothalamus .c 844 to 1331 1 to 488     Submitted on the opposite strand 488/488
(100 %)
0 diff
(100 %id)
W16684 lung .c 850 to 1322 1 to 472   fully sequenced,   472/472
(100 %)
5 diff
(99.0 %id)
CF619210 Pooled Chondrosarcoma Tumor cells .c 853 to 1330 39 to 515   AAA   477/515
(92 %)
6 diff
(98.9 %id)
AW448966   .c 855 to 1330 493 to 18   AAA   476/476
(100 %)
2 diff
(99.6 %id)
DB575176 hypothalamus .c 856 to 1331 1 to 476     Submitted on the opposite strand 476/476
(100 %)
0 diff
(100 %id)
CF146784 CNCAP(3)T-225 cell line, Prostate .c 865 to 1330 495 to 30   AAA Submitted on the opposite strand 466/468
(99 %)
1 diff
(99.8 %id)
TI_154179309   .c 865 to 1330 556 to 91   AAA Submitted on the opposite strand 466/791
(58 %)
1 diff
(99.9 %id)
BX329857 Neuroblastoma Cot 50-normalized .c 867 to 1331 465 to 1   fully sequenced,   465/465
(100 %)
4 diff
(99.2 %id)
AA838388 Kidney, kidney tumor .c 868 to 1341 475 to 1       475/475
(100 %)
17 diff
(96.5 %id)
AI983116 pooled germ cell tumors .c 877 to 1339 474 to 12   AAA   463/463
(100 %)
1 diff
(99.8 %id)
DB511387 testis .c 880 to 1330 1 to 451     Submitted on the opposite strand 451/451
(100 %)
7 diff
(98.5 %id)
AW769101 colon, moderately-differentiated adenocarcinoma .c 880 to 1330 469 to 19   AAA   451/451
(100 %)
3 diff
(99.4 %id)
AI767753 Kidney .c 883 to 1330 448 to 1       448/448
(100 %)
0 diff
(100 %id)
AI948835 pooled germ cell tumors .c 889 to 1323 435 to 1       435/435
(100 %)
0 diff
(100 %id)
AI370568   .c 893 to 1327 436 to 2       435/464
(93 %)
14 diff
(97.0 %id)
TI_149283426   .c 893 to 1323 520 to 90   AAA   431/673
(64 %)
8 diff
(98.9 %id)
BM984015 lung, Primary Lung Epithelial Cells .c 893 to 1323 447 to 17   AAA   431/463
(93 %)
8 diff
(98.3 %id)
DB507659 testis .c 895 to 1330 1 to 438     Submitted on the opposite strand 438/438
(100 %)
12 diff
(97.3 %id)
FN141048 breast carcinoma .c 896 to 986 89 to 1     Submitted on the opposite strand 89/91
(97 %)
2 diff
(97.9 %id)
AA733032 heart .c 896 to 1328 435 to 2       434/436
(99 %)
2 diff
(99.6 %id)
AI691056 colon, colonic mucosa from 5 ulcerative colitispatients .c 896 to 1273 386 to 7       380/387
(98 %)
7 diff
(98.2 %id)
AI312519 2 pooled tumors (clear cell type), Kidney .c 900 to 1335 436 to 1       436/437
(99 %)
4 diff
(99.1 %id)
CB241836 Human Lung Epithelial cells, lung .c 913 to 1330 436 to 19   AAA   418/427
(97 %)
0 diff
(100 %id)
AA641441 epithelium (cell line), Prostate .c 916 to 1125 211 to 1       211/211
(100 %)
1 diff
(99.6 %id)
CB987203 Pooled-Glandular .c 921 to 1330 1 to 410       410/414
(99 %)
3 diff
(99.3 %id)
AW672670 cervix .c 928 to 1001 1 to 74   fully sequenced,   74/74
(100 %)
1 diff
(98.7 %id)
AI968691 pooled germ cell tumors .c 931 to 1339 419 to 11       409/419
(97 %)
0 diff
(100 %id)
BX357145 Placenta Cot 25-normalized .c 934 to 1293 359 to 1   fully sequenced,   359/359
(100 %)
14 diff
(96.2 %id)
BM841562 lymph node, stomach .c 952 to 1345 1 to 394   AAA   394/394
(100 %)
0 diff
(100 %id)
BQ187165 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 952 to 1241 1 to 290   fully sequenced,   290/290
(100 %)
1 diff
(99.7 %id)
BF678146 Prostate .c 955 to 1327 1 to 375   AAA   375/983
(38 %)
14 diff
(98.6 %id)
AI745361 ovary, tumor, 5 pooled (see description) .c 956 to 1336 382 to 2       381/382
(99 %)
0 diff
(100 %id)
AW673726 cervix .c 958 to 1330 373 to 1   fully sequenced,   373/373
(100 %)
0 diff
(100 %id)
AW615793 lung, small cell carcinoma .c 961 to 1330 374 to 5       370/422
(87 %)
7 diff
(98.4 %id)
BE328771 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .c 963 to 1345 389 to 7       383/389
(98 %)
0 diff
(100 %id)
AL559386 T cells from T cell leukemia .c 970 to 1262 333 to 41   fully sequenced,   293/299
(97 %)
0 diff
(100 %id)
D11592 Liver .c 970 to 1319 1 to 354       354/361
(98 %)
8 diff
(97.8 %id)
D11608 Liver .c 970 to 1318 1 to 353       353/359
(98 %)
10 diff
(97.3 %id)
D11879 Liver .c 970 to 1330 1 to 363       363/366
(99 %)
4 diff
(99.0 %id)
N79531 lung .c 970 to 1330 362 to 1   fully sequenced,   362/362
(100 %)
1 diff
(99.8 %id)
AW675422 cervix .c 970 to 1335 366 to 1   fully sequenced,   366/366
(100 %)
3 diff
(99.2 %id)
CK301199 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 970 to 1241 293 to 22   fully sequenced,   272/293
(92 %)
0 diff
(100 %id)
AI352285   .c 980 to 1327 349 to 4       346/350
(98 %)
1 diff
(99.8 %id)
AI568807 Prostate .c 1001 to 1330 331 to 2       330/332
(99 %)
0 diff
(100 %id)
AW241457 pooled germ cell tumors .c 1001 to 1322 322 to 1       322/329
(97 %)
1 diff
(99.7 %id)
AA583830 larynx .c 1003 to 1322 320 to 1       320/320
(100 %)
0 diff
(100 %id)
BM855171 stomach .c 1035 to 1175 1 to 141       141/141
(100 %)
1 diff
(99.3 %id)
BG186766   .c 1068 to 1310 255 to 12     Submitted on the opposite strand 244/255
(95 %)
0 diff
(100 %id)
BG211570   .c 1077 to 1330 266 to 12     Submitted on the opposite strand 255/266
(95 %)
0 diff
(100 %id)
AA759230   .c 1081 to 1327 250 to 1       250/250
(100 %)
1 diff
(99.6 %id)
BQ012726 placenta .c 1085 to 1330 264 to 19   AAA   246/246
(100 %)
1 diff
(99.6 %id)
AI942377 Kidney .c 1143 to 1345 205 to 3       203/205
(99 %)
0 diff
(100 %id)
AA055004 heart .c 1174 to 1328 156 to 6       151/156
(96 %)
0 diff
(100 %id)
FN118601 breast carcinoma .c 1195 to 1291 93 to 1     Submitted on the opposite strand 93/93
(100 %)
4 diff
(95.7 %id)
FN068473 breast carcinoma .c 2382 to 2498 1 to 114   tiling clone,   114/114
(100 %)
7 diff
(93.9 %id)
DB294070   .c 2549 to 3386 2 to 838   tiling clone, capped   837/840
(99 %)
6 diff
(99.3 %id)
BU569265 testis .c 2659 to 3314 1 to 658       658/803
(81 %)
13 diff
(98.4 %id)
BG106335 lymph, lymphoma, cell line .c 2758 to 3190 28 to 462       435/464
(93 %)
4 diff
(99.2 %id)
BX090889 Prostate .c 3369 to 3857 1 to 489   tiling clone,   489/489
(100 %)
1 diff
(99.8 %id)
M79158   .c 3528 to 3868 346 to 1   tiling clone,   346/348
(99 %)
6 diff
(98.3 %id)
AI741088 pooled .c 3604 to 3857 272 to 19   tiling clone, AAA   254/254
(100 %)
1 diff
(99.7 %id)
AI805220 Prostate .c 3651 to 3857 207 to 1       207/207
(100 %)
1 diff
(99.6 %id)
DB384049   .c 3893 to 4437 544 to 1   tiling clone,   544/559
(97 %)
9 diff
(98.4 %id)
BF363464 nervous_normal .c 3895 to 4140 1 to 246   tiling clone,   246/246
(100 %)
3 diff
(98.8 %id)
BI493448 cochlea, ear .c 4050 to 4437 8 to 395   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 388/395
(98 %)
6 diff
(98.5 %id)
BI493447 cochlea, ear .c 4089 to 4435 347 to 1   fully sequenced, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 347/347
(100 %)
0 diff
(100 %id)
DA998302   .c 5234 to 5810 2 to 578   tiling clone, capped   577/577
(100 %)
0 diff
(100 %id)
DA798702 brain .c 5335 to 5863 2 to 530   tiling clone, capped   529/531
(99 %)
1 diff
(99.9 %id)
DA159780 amygdala .c 5826 to 6391 2 to 571   tiling clone, capped   570/570
(100 %)
9 diff
(98.5 %id)
DA327600 hippocampus .c 6121 to 6641 2 to 523   tiling clone, capped   522/522
(100 %)
1 diff
(99.9 %id)
CA943291 Pancreas, Purified pancreatic islet .c 7614 to 8075 1 to 461   tiling clone,   461/461
(100 %)
3 diff
(99.4 %id)
DA218626 brain .c 7798 to 8466 2 to 670   capped   669/669
(100 %)
2 diff
(99.8 %id)
DB302092 amygdala .c 7836 to 8405 570 to 1       570/570
(100 %)
1 diff
(99.9 %id)
DB179024 kidney, tumor tissue .c 7850 to 8433 2 to 584   tiling clone, capped   583/583
(100 %)
3 diff
(99.5 %id)
AA021185 eye, retina .c 7872 to 8311 1 to 447       447/465
(96 %)
11 diff
(97.7 %id)
R84687 eye, retina .c 7873 to 8262 1 to 396       396/396
(100 %)
7 diff
(98.3 %id)
AI478617 Kidney .c 7937 to 8411 475 to 1       475/475
(100 %)
1 diff
(99.8 %id)
DA170439 amygdala .c 8009 to 8532 2 to 526   capped   525/525
(100 %)
1 diff
(99.9 %id)
CA943409 Pancreas, Purified pancreatic islet .c 8101 to 8405 305 to 1       305/305
(100 %)
0 diff
(100 %id)
AL712838 human skeletal muscle .c 8114 to 8605 1 to 492   tiling clone,   492/492
(100 %)
1 diff
(99.8 %id)
AI091632 pooled .c 8600 to 9052 463 to 11   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 453/453
(100 %)
0 diff
(100 %id)
AL703750 human skeletal muscle .c 8642 to 9242 1 to 601       601/601
(100 %)
2 diff
(99.7 %id)
DA725761   .c 8781 to 9336 2 to 558   tiling clone, capped   557/557
(100 %)
1 diff
(99.9 %id)
DB215395 trachea .c 9314 to 9864 2 to 552   tiling clone, capped   551/551
(100 %)
1 diff
(99.9 %id)
DA124812 cerebellum .c 9410 to 9942 2 to 533   capped   532/533
(99 %)
4 diff
(99.3 %id)
DB326828 brain .c 9710 to 10279 567 to 1   tiling clone,   567/567
(100 %)
1 diff
(99.9 %id)
DB347522 kidney, tumor tissue .c 9764 to 10263 499 to 1       499/499
(100 %)
4 diff
(99.2 %id)
AA021186 eye, retina .c 9878 to 10294 416 to 1       416/422
(98 %)
3 diff
(99.3 %id)
R85650 eye, retina .c 10056 to 10252 196 to 3       194/196
(98 %)
0 diff
(100 %id)
DA778397 brain .c 10069 to 10647 9 to 587   capped   579/586
(98 %)
6 diff
(99.0 %id)
DA353911 substantia nigra .c 10177 to 10750 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DA253288 caudate nucleus .c 10183 to 10776 2 to 595   tiling clone, capped   594/594
(100 %)
0 diff
(100 %id)
DA351404 substantia nigra .c 10348 to 10938 2 to 592   tiling clone, capped   591/591
(100 %)
0 diff
(100 %id)
AK094744 brain .c 10362 to 12728 1 to 2363   tiling clone, available from FLJ,   2363/2363
(100 %)
5 diff
(99.8 %id)
DA198454 brain .c 10363 to 10915 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
DB195051 trachea .c 10380 to 10890 2 to 513   capped   512/512
(100 %)
1 diff
(99.9 %id)
T33632 brain .c 10998 to 11395 1 to 398       398/402
(99 %)
1 diff
(99.8 %id)
AW953311   .c 11017 to 11513 1 to 498       498/498
(100 %)
10 diff
(98.0 %id)
DA138790 alzheimer cortex .c 11058 to 11603 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
Z44298 brain, total brain .c 11158 to 11507 1 to 350       350/350
(100 %)
0 diff
(100 %id)
BX114605 senescent fibroblast .c 11272 to 11833 1 to 562   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 562/562
(100 %)
1 diff
(99.9 %id)
AA284185 senescent fibroblast .c 11272 to 11738 1 to 467     Submitted on the opposite strand 467/467
(100 %)
1 diff
(99.8 %id)
AF086195   .c 11272 to 11840 573 to 5     Submitted on the opposite strand 569/573
(99 %)
0 diff
(100 %id)
W47507 senescent fibroblast .c 11272 to 11576 1 to 309       309/312
(99 %)
7 diff
(97.8 %id)
AI767534 Kidney .c 11345 to 11834 490 to 1       490/490
(100 %)
2 diff
(99.6 %id)
N57595 multiple sclerosis lesions .c 11368 to 11757 1 to 397       397/397
(100 %)
13 diff
(96.8 %id)
AA639117 Ewing's sarcoma .c 11372 to 11837 30 to 494       465/517
(89 %)
4 diff
(99.3 %id)
W47508 senescent fibroblast .c 11422 to 11837 421 to 2       420/421
(99 %)
0 diff
(100 %id)
BG398977 Kidney .c 11544 to 12291 1 to 741       741/781
(94 %)
29 diff
(96.3 %id)
AA318940 adrenal gland .c 11620 to 11998 1 to 382       382/396
(96 %)
11 diff
(97.3 %id)
TI_149302514   .c 11901 to 12723 891 to 73   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 819/974
(84 %)
11 diff
(98.9 %id)
CB047554 Kidney .c 11919 to 12233 3 to 317   fully sequenced, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 315/317
(99 %)
5 diff
(98.5 %id)
BM980695 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 12053 to 12723 689 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 671/673
(99 %)
0 diff
(100 %id)
BM669544 eye, fetal eyes .c 12110 to 12725 632 to 17   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 616/616
(100 %)
0 diff
(100 %id)
DB324367   .c 12143 to 12725 583 to 1       583/583
(100 %)
1 diff
(99.9 %id)
DB303879 brain .c 12166 to 12728 563 to 1       563/563
(100 %)
1 diff
(99.9 %id)
DB349041 trachea .c 12182 to 12731 550 to 1   tiling clone,   550/550
(100 %)
0 diff
(100 %id)
DB301223 alzheimer cortex .c 12203 to 12728 526 to 1       526/526
(100 %)
0 diff
(100 %id)
CB047553 Kidney .c 12203 to 12723 549 to 29   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 521/521
(100 %)
1 diff
(99.9 %id)
N52773 multiple sclerosis lesions .c 12254 to 12724 471 to 1       471/471
(100 %)
0 diff
(100 %id)
BX089561 brain .c 12359 to 12600 1 to 243       243/243
(100 %)
1 diff
(99.6 %id)
H21246 brain .c 12359 to 12710 1 to 357       357/375
(95 %)
8 diff
(97.9 %id)
H19531 brain .c 12359 to 12701 1 to 353       353/387
(91 %)
13 diff
(96.7 %id)
BF508613   .c 12364 to 12723 377 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 360/370
(97 %)
0 diff
(100 %id)
T33631 brain .c 12397 to 12723 328 to 1       328/328
(100 %)
2 diff
(99.4 %id)
Z40258 brain, total brain .c 12433 to 12725 293 to 1       293/293
(100 %)
0 diff
(100 %id)
AL704170 human skeletal muscle .d 1 to 690 1 to 690   tiling clone,   690/690
(100 %)
1 diff
(99.9 %id)
BP362182 thalamus .d 25 to 605 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA285033 corpus callosum .d 26 to 568 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
CR606085 Neuroblastoma Cot 50-normalized .d 41 to 1575 1 to 1535 exact tiling clone,   1535/1535
(100 %)
0 diff
(100 %id)
AL529348 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 41 to 809 1 to 770   fully sequenced,   770/770
(100 %)
9 diff
(98.9 %id)
DA235923 brain .d 43 to 618 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
CR989905 T-Lymphocytes .d 55 to 601 1 to 547       547/547
(100 %)
0 diff
(100 %id)
AL529347 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 748 to 1575 828 to 1   fully sequenced,   828/828
(100 %)
12 diff
(98.6 %id)
BG437325 large cell carcinoma, lung .e 1 to 661 9 to 676   tiling clone,   676/788
(85 %)
21 diff
(97.4 %id)
BM562273 amelanotic melanoma, cell line, skin .e 14 to 882 1 to 872 A136P A141T C155R tiling clone,   872/1006
(86 %)
19 diff
(98.2 %id)
TI_59394056   .e 21 to 730 83 to 800       718/884
(81 %)
18 diff
(98.0 %id)
BM015787 breast, mammary adenocarcinoma, cell line .e 22 to 730 1 to 717       717/883
(81 %)
18 diff
(98.0 %id)
BU600447 mixed (pool of 40 RNAs) .e 57 to 847 1 to 805 G66R E82A E96D T102Y K103Q ... tiling clone,   805/815
(98 %)
44 diff
(94.7 %id)
AA188528   .f 1 to 298 1 to 304   tiling clone,   304/304
(100 %)
10 diff
(96.8 %id)
BM723994 eye, fetal eye .f 219 to 804 1 to 586   tiling clone, fully sequenced,   586/586
(100 %)
0 diff
(100 %id)
AA186873   .f 722 to 1187 466 to 1   tiling clone,   466/466
(100 %)
0 diff
(100 %id)
BU742040 eye, fetal eye .f 743 to 1215 492 to 19   tiling clone, fully sequenced, AAA   474/474
(100 %)
1 diff
(99.8 %id)
CN261961 embryonic stem cells, DMSO-treated H9 cellline .g 1 to 576 1 to 576   tiling clone,   576/576
(100 %)
3 diff
(99.5 %id)
CT000896 T-Lymphocytes .g 2 to 751 1 to 753       753/753
(100 %)
3 diff
(99.7 %id)
BI085155 astrocytoma grade IV, cell line, brain .g 3 to 505 1 to 507       507/745
(68 %)
29 diff
(96.2 %id)
BI116198 lung, small cell carcinoma .g 5 to 916 1 to 907 D38G K39*     905/908
(99 %)
30 diff
(96.7 %id)
BQ652992 hepatocellular carcinoma, cell line, Liver .g 15 to 947 1 to 937 L57P V78G Y85D N86H L88S ...     937/974
(96 %)
33 diff
(96.7 %id)
BQ643700 hepatocellular carcinoma, cell line, Liver .g 15 to 842 1 to 829   tiling clone,   829/959
(86 %)
4 diff
(99.6 %id)
BQ652226 hepatocellular carcinoma, cell line, Liver .g 15 to 569 1 to 559       559/994
(56 %)
10 diff
(99.0 %id)
BQ644580 hepatocellular carcinoma, cell line, Liver .g 15 to 843 1 to 835       835/870
(95 %)
12 diff
(98.7 %id)
BE266542 lung, small cell carcinoma .g 17 to 635 1 to 615       615/630
(97 %)
10 diff
(98.5 %id)
BE302707 melanotic melanoma, skin .g 20 to 522 1 to 502       502/502
(100 %)
2 diff
(99.7 %id)
BQ233107 melanotic melanoma, skin .g 105 to 734 38 to 675       638/938
(68 %)
27 diff
(97.2 %id)
BI085793 astrocytoma grade IV, cell line, brain .g 526 to 1107 604 to 13       592/605
(97 %)
0 diff
(100 %id)
BE207532 melanotic melanoma, skin .g 634 to 1172 542 to 4   tiling clone,   539/550
(98 %)
2 diff
(99.7 %id)
BM555082 amelanotic melanoma, cell line, skin .h 1 to 814 1 to 826 A72T C86R tiling clone,   826/1100
(75 %)
27 diff
(97.6 %id)
BF753843 colon .i 1 to 410 1 to 428   tiling clone,   428/444
(96 %)
15 diff
(96.7 %id)
AW020231 cochlea, ear .i 4 to 411 1 to 409   tiling clone,   409/409
(100 %)
4 diff
(99.1 %id)
BF790356 muscle (skeletal) .i 16 to 685 1 to 672   tiling clone,   672/845
(79 %)
19 diff
(97.8 %id)
BI491279 cochlea, ear .i 484 to 1117 662 to 29 L47F L59F tiling clone, AAA   634/634
(100 %)
4 diff
(99.4 %id)
BM016655 astrocytoma grade IV, cell line, brain .j 1 to 646 7 to 652 C5R L59* tiling clone,   652/652
(100 %)
6 diff
(99.1 %id)
TI_59386888   .j 1 to 646 105 to 750 C5R L59*     651/651
(100 %)
5 diff
(99.3 %id)
BM912116 amelanotic melanoma, cell line, skin .j 44 to 565 1 to 522   tiling clone,   522/1192
(43 %)
12 diff
(99.0 %id)
DB462348 testis .k 1 to 481 2 to 482 exact tiling clone,   482/482
(100 %)
2 diff
(99.6 %id)
CD657536 Embryonic Stem cells .l-u 1 to 784 12 to 789 F21C tiling clone,   778/794
(97 %)
8 diff
(99.0 %id)
BX475929   .m-u 1 to 514 1 to 514 exact tiling clone,   514/514
(100 %)
6 diff
(98.9 %id)
BU632043 cell lines, Chondrosarcoma Gene DCUN1D5, variant not shown       AAA This clone was ignored    
AL603339 human skeletal muscle Gene DCUN1D5, variant not shown              
AL692046   Gene DCUN1D5, variant not shown              
BP871959 embryonal kidney Gene DCUN1D5, variant not shown              
BP308470 brain Gene DCUN1D5, variant not shown         Suspected internal deletion, this clone was ignored    
DB318253   Gene DCUN1D5, variant not shown         This clone was ignored    
DA549203   Gene DCUN1D5, variant not shown       capped This clone was ignored    
BX427519 fetal liver, Liver Gene DCUN1D5, variant not shown       fully sequenced, This clone was ignored    
BX427520 fetal liver, Liver Gene DCUN1D5, variant not shown       fully sequenced, This clone was ignored    
DB120025 thymus Gene DCUN1D5, variant not shown       capped      
DB343900 thymus Gene DCUN1D5, variant not shown              
DB126679 thymus Gene DCUN1D5, variant not shown       capped      
DA381133 thalamus Gene DCUN1D5, variant not shown       capped      
H71125 liver and spleen Gene DCUN1D5, variant not shown              
H71126 liver and spleen Gene DCUN1D5, variant not shown              
AW135640   Gene DCUN1D5, variant not shown       AAA      
AW272223 colon, moderately-differentiated adenocarcinoma Gene DCUN1D5, variant not shown              
BE615964 adenocarcinoma, Pancreas Gene DCUN1D5, variant not shown         This clone was ignored    
BE616765 adenocarcinoma, Pancreas Gene DCUN1D5, variant not shown         This clone was ignored    
BE886536 leiomyosarcoma, uterus Gene DCUN1D5, variant not shown         Suspected internal deletion, this clone was ignored    
BG111337 Bone, osteosarcoma, cell line Gene DCUN1D5, variant not shown              
BG676035 skin, squamous cell carcinoma Gene DCUN1D5, variant not shown         This clone was ignored    
BM008874 adenocarcinoma, Pancreas Gene DCUN1D5, variant not shown         This clone was ignored    
TI_59386592   Gene DCUN1D5, variant not shown         This clone was ignored    
TI_159697202   Gene DCUN1D5, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C